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ABSTRACT
Objectives Local authorities (LAs) in England
commission chlamydia screening as part of the National
Chlamydia Screening Programme. It is recommended
that LAs achieve a chlamydia diagnosis rate of ≥2300
cases per 100 000 population aged 15–24. We describe
national patterns in attainment of the chlamydia
diagnosis rate recommendation and possible implications
of using it to measure LA-level performance.
Methods We used publicly available data sets from
England (2012) to explore the association between LAs
attaining the recommended chlamydia diagnosis rate
and population size, socioeconomic deprivation, test
setting and sex.
Results We used data from 1 197 121 recorded
chlamydia tests in females and 564 117 in males. The
chlamydia diagnosis rate recommendation was achieved
by 22% (72/324) of LAs overall (43% female
population; 8% male population). LAs in the highest
deprivation quintile were more likely to reach the
recommendation than those in the least-deprived quintile
for both sexes (women: unadjusted prevalence ratio
(UPR) 7.43, 95% CI 3.65 to 15.11; men: UPR 7.00,
95% CI 1.66 to 29.58). The proportion of tests
performed in genitourinary medicine clinics was
negatively associated with attainment of the
recommended diagnosis rate (UPR 0.95, 0.93 to 0.97).
Conclusions Chlamydia diagnosis rate
recommendations that reﬂect local area deprivation (as a
proxy for disease burden) may be more appropriate than
a single national target if the aim is to reduce health
inequalities nationally. We suggest LAs monitor their
chlamydia diagnosis rate, test coverage and test
positivity across a range of measures (including setting
and sex) and pre/post changes to commissioned services.
Critical evaluation of performance against the
recommendation should be reﬂected in local
commissioning decisions.
INTRODUCTION
Chlamydia infection, caused by Chlamydia tracho-
matis, is the most commonly diagnosed STI in
England.1 National surveys performed in the UK
have estimated that the prevalence of infection is
highest among young women of 18–19 years
(4.7%; 95% CI 2.5% to 8.6% in 2010–2012) and
men of 20–24 years (3.4%; 2.2% to 5.2%).2
A National Chlamydia Screening Programme
(NCSP) was introduced in 2003 in England by the
Department of Health. The aim was to control
chlamydia prevalence, transmission and reduce
reproductive tract morbidity. The NCSP recom-
mends opportunistic screening for sexually active
males and females under 25 years, annually or after
a partner change, whichever is more frequent.
Testing occurs in a variety of settings, including
genitourinary medicine (GUM) clinics, general
practice, schools and youth centres.
It is difﬁcult and costly to obtain prevalence
estimates for chlamydia. Therefore, NCSP perform-
ance monitoring has focused on process measures.
The previous annual target of 35% coverage of
15–24 year olds was criticised because it did not
encourage services to target individuals most at-risk
of infection.3 A novel indicator, the chlamydia
diagnosis rate, was introduced in 2013 by Public
Health England (PHE) within the Public Health
Outcomes Framework. PHE recommends that each
local authority (LA) (governmental administrative
areas of England) achieve a chlamydia diagnosis
rate of ≥2300 cases per 100 000 residents aged
15–24 years per year.4
The chlamydia diagnosis rate is calculated by
dividing the number of unique positive tests
performed within the NCSP by the total popula-
tion aged 15–24 years. This is equivalent to multi-
plying test coverage (the proportion of the
population screened) with positivity (the propor-
tion of tests that are positive) and, therefore, it
encourages targeting resource towards at-risk indi-
viduals and community-wide screening.4 5 There
are currently no published studies that explore the
relationship between chlamydia diagnosis rate and
external factors. But coverage and positivity are
associated with a multitude of factors that differ
across LAs, including gender,2 population size or
urbanisation,6 socioeconomic status7 8 and type of
testing facility. We describe patterns in the national
attainment of the chlamydia diagnosis rate indica-
tor and the possible implications of using it to
measure LA-level performance.
METHODS
We used the 2012 NCSP data set (NCSP website
05/03/2014), which contains all chlamydia tests
performed and all diagnoses reported in people
aged 15–24 in England during 2012 by LA.9 The
data set also contains the location where tests were
performed (GUM clinics or non-GUM settings) for
the combined population (male and female) and
the 15- to 24-year-old population size by sex (from
2011 census). We used the Indices of Multiple
Deprivation 2010 data set (which contains a
deprivation score for each Lower Super Output
Area, a subdivision of LAs that have a population
of 1000–3000) to calculate a weighted-average
socioeconomic deprivation score for each LA.10
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Separately for the male and female population in each LA, we
calculated the chlamydia diagnosis rate per 100 000 residents
aged 15–24. This calculation assumes that each test is from a
unique person. We categorised LAs into those that achieved and
those that did not achieve the recommended chlamydia diagno-
sis rate. We calculated unadjusted prevalence ratios (PRs) to
explore the relationship between attaining the recommendation
and population size, and deprivation by sex and then the pro-
portion of tests in GUM clinics for the overall population. We
carried out a χ2 test for trend in R (V.3.2.4) to explore the evi-
dence for a trend in the proportions attaining the recommenda-
tion according to categories of IMD and population size. Ethics
committee approval was not sought for this study.
RESULTS
The 2012 NCSP data set included 1 197 121 recorded chla-
mydia tests in females and 564 117 in males aged 15–24 years
in 326 LAs. We excluded two LAs (NCSP data set recorded
‘<5’ for key variables). For the overall population, the chla-
mydia diagnosis rate recommendation was achieved by 72 of
324 (22%) LAs, and the mean chlamydia diagnosis rate for
England was 1800 per 100 000. For women, nearly half (139/
324, 43%) of all LAs achieved the recommendation with a
mean of 2338 per 100 000 (table 1). For men, <10% (26/324,
8%) of LAs attained the recommendation with a mean diagnosis
rate of 1244 per 100 000.
LAs in the most socioeconomically deprived quintile were
more likely to achieve the recommendation than those in the
least-deprived quintile for both women (PR 7.43, 95% CI 3.65
to 15.11, χ2 test for trend p≤ 0.001) and men (PR 7.00, 1.66
to 29.58, χ2 p≤ 0.001). In the overall population, the propor-
tion of tests carried out in a GUM setting was negatively asso-
ciated with attaining the recommendation (PR 0.95 (0.93 to
0.97)). LAs with larger female populations were more likely to
attain the recommended chlamydia diagnosis rate than those
with a smaller population (χ2 test for trend p≤0.0001), but
there was no clear association between achieving the
recommendation and population size for men (p=0.2619, see
online supplementary table S1).
DISCUSSION
The chlamydia diagnosis rate recommendation of ≥2300 cases
per 100 000 population aged 15–24 was more likely to be
attained by LAs with higher levels of socioeconomic deprivation
and those where a higher proportion of tests were performed
outside the GUM setting. It was also more likely to be reached
in the female population compared with the male population.
While LAs can inﬂuence the location of chlamydia testing
through commissioning arrangements, the association between
deprivation and attaining the recommended level suggests that
using the chlamydia diagnosis rate to compare performance
across LAs is difﬁcult.
To our knowledge, this is the ﬁrst study that explores the
novel chlamydia diagnosis rate recommendation for the NCSP
in England. We have performed a secondary analysis of publicly
available data sets and our ﬁndings are limited by the quality of
these data. However, the Chlamydia Testing Activity Dataset
used in this analysis has considerably improved the quantity and
utility of NCSP data.11 It includes all chlamydia tests performed
in National Health Service or LA-commissioned laboratories;
residence details to allocate cases to LAs; and it can be linked to
GUM data to reduce ‘double-counting’ cases diagnosed in
non-GUM settings but referred to GUM.
It was not possible to adjust the population denominator by
the proportion who are sexually active and if this parameter
varies by LA it could bias our ﬁndings. In addition, the available
data assume that each test is a unique person. It is likely, given
the policy recommendation for repeat testing following a posi-
tive test or change of sexual partner, that a proportion of
people are tested more than once per year and, therefore, esti-
mated coverage is likely to overestimate true population cover-
age. The weighted-average deprivation scores we used compare
area rather than individual-level deprivation; therefore, LA
values may not reﬂect the individuals participating with
Table 1 Coverage, positivity, chlamydia diagnosis rate and unadjusted PRs for the association between achieving a chlamydia diagnosis rate of
≥2300 cases per 100 000 by quintile of socioeconomic deprivation (IMD) and sex for LAs in England in 2012
IMD quintile No of LAs
LAs meeting
recommendation
(%) Coverage (%) Positivity (%)
Chlamydia
diagnosis rate
per 100 000
Unadjusted PR (95% CI)N Per cent Mean SD Mean SD Mean SD
Women
1* 65 52 80.00 39.65 11.91 7.97 1.09 3176 1128 7.43 (3.65 to 15.11)
2 65 36 55.38 37.36 14.43 7.27 1.40 2651 946 5.14 (2.47 to 10.70)
3 64 27 42.19 32.84 16.19 7.31 1.36 2357 1147 3.92 (1.84 to 8.35)
4 65 17 26.15 26.54 7.63 6.76 1.18 1791 596 2.43 (1.08 to 5.46)
5† 65 7 10.77 27.34 16.62 6.43 1.16 1713 966 Reference
Men
1* 65 14 21.54 19.22 8.47 9.90 2.98 1772 756 7.00 (1.66 to 29.58)
2 65 7 10.77 16.55 9.45 9.52 2.69 1434 586 3.50 (0.76 to 16.22)
3 64 5 7.81 14.18 10.11 9.19 3.15 1175 645 2.54 (0.51 to 12.61)
4 65 0 0 11.11 4.89 8.85 2.31 921 291 ‡
5† 65 2 3.08 12.47 8.82 8.36 2.36 919 448 Reference
*IMD 1 is the most-deprived quintile.
†IMD 5 is the least-deprived quintile.
‡Data omitted because no LAs in IMD quintile 4 met chlamydia diagnosis rate recommendation.
IMD, index of multiple deprivation; LA, local authority; PR, prevalence ratio.
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chlamydia testing, and individual-level data are needed to fully
understand the local picture.
The introduction of the chlamydia diagnosis rate indicator is
a shift from a process measure of 35% coverage to a consider-
ation of whether testing is achieving the aim of identifying
asymptomatic infections. Our interpretation of this study
assumes that achieving this recommendation is a marker for
‘better’ chlamydia control activity. But the impact of diagnosing
asymptomatic infections in men and the relationship between
testing rates and population prevalence of infection are not
known. Further research is needed to determine how the chla-
mydia diagnosis rate is expected to change to reﬂect adequate
control of the infection.
Our ﬁndings suggest that using the chlamydia diagnosis rate
as a national public health indicator may be compromised
by the inﬂuence of external factors. More afﬂuent LAs were
less likely to attain the recommendation compared with the
most-deprived areas. This study was not able to explore the
mechanism of this association but potential causes include more
appropriate targeting of testing or a higher disease burden in
deprived areas. There is a well-documented association in the
UK between increasing area-level deprivation and chlamydia
infection (combined OR from meta-analysis of three studies
1.76, 95% CI 1.15 to 2.71).8
The negative association between the proportion of tests in
GUM clinics and reaching the chlamydia diagnosis rate recom-
mendation may suggest the need for more testing outside of this
setting, particularly in the least-deprived areas. A potential
explanation for this is that chlamydia (unlike gonorrhoea and
other STIs) is not typically concentrated in higher risk indivi-
duals who may preferentially present to GUM clinics rather
than primary care. Further analysis of chlamydia diagnosis rate
in GUM clinics, compared with non-GUM settings, by sex,
could help commissioners to determine the ideal balance of
testing locations.
We observed a marked difference in the mean chlamydia diag-
nosis rate by sex. This may reﬂect the higher prevalence of chla-
mydial infection in young women shown by the recent UK
National Survey of Sexual Attitudes and Lifestyles (prevalence in
women 16–24 years was 3.1% (2.2–4.3); 2.3% (1.5–3.4) in men2)
or it may highlight a need to encourage screening among men.
Implications for policy makers
Recommending a consistent chlamydia diagnosis rate to LAs
with potentially differing local burdens of infection8 may result
in an overinvestment of resource relative to health need in afﬂu-
ent areas. Therefore, adjusting the recommendation by area
socioeconomic status, as a proxy for local disease burden, may
be more appropriate than a single national recommendation.
We suggest that LAs are encouraged to evaluate their chla-
mydia diagnosis rate attainment, test coverage and positivity
across a range of measures (including service, sex, geographic
area (lower super output area)) and before and after changes to
commissioned services. Critical evaluation of LA performance
against the recommendation should be reﬂected locally in com-
missioning decisions and nationally in subsequent versions of
the Public Health Outcomes Framework.
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